购物车
- 全部删除
- 您的购物车当前为空
ACT 178882 is a new Renin inhibitor (IC50: 1.4 nM).
ACT 178882 is a new Renin inhibitor (IC50: 1.4 nM).
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 21,600 | 10-14周 | |
50 mg | ¥ 28,800 | 10-14周 | |
100 mg | ¥ 37,500 | 10-14周 |
产品描述 | ACT 178882 is a new Renin inhibitor (IC50: 1.4 nM). |
靶点活性 | Renin:1.4 nM |
体外活性 | The median time to Cmax (tmax) for ACT 178882 is prolonged from 3.5 to 5.0 h by diltiazem whereas its apparent terminal half-life (t?) is unaffected by diltiazem, 22.9 and 24.2 h for treatments A and B, respectively. Using treatment A as reference, the geometric mean ratio (90% CI) is 1.62 (1.36 to 1.94) for Cmax and 2.02 (1.75 to 2.34) for AUC∞, indicating a significant interaction between ACT 178882 and diltiazem[2]. |
分子量 | 647.03 |
分子式 | C33H38Cl3N3O4 |
CAS No. | 1007392-69-9 |
密度 | 1.33 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容